1. Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers
- Author
-
Nur Aziah Hanapi, Siti R. Yusof, Nelson Jeng Yeou Chear, and Juzaili Azizi
- Subjects
Coping (psychology) ,drug-drug interactions ,Mitragyna speciosa ,RM1-950 ,Review ,Pharmacology ,alkaloids ,chemistry.chemical_compound ,medicine ,mitragynine ,Pharmacology (medical) ,Receptor ,Barrier function ,chemistry.chemical_classification ,biology ,receptor-binding ,kratom ,medicine.disease ,biology.organism_classification ,Substance abuse ,barrier permeability ,Enzyme ,chemistry ,Mitragynine ,Barrier permeability ,Therapeutics. Pharmacology ,metabolism - Abstract
Parallel to the growing use of kratom, there is a wealth of evidence from self-report, preclinical, and early clinical studies on therapeutic benefits of its alkaloids in particular for treating pain, managing substance use disorder, and coping with emotional or mental health conditions. On the other hand, there are also reports on potential health risks concerning kratom use. These two aspects are often discussed in reviews on kratom. Here, we aim to highlight specific areas that are of importance to give insights into the mechanistic of kratom alkaloids pharmacological actions. This includes their interactions with drug-metabolizing enzymes and predictions of clinical drug-drug interactions, receptor-binding properties, interactions with cellular barriers in regards to barrier permeability, involvement of membrane transporters, and alteration of barrier function when exposed to the alkaloids.
- Published
- 2021
- Full Text
- View/download PDF